Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Unternehmen & Branche
| Name | ANI PHARMACEUTICALS INC |
|---|---|
| Ticker | ANIP |
| CIK | 0001023024 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 00182C103 |
|---|---|
| ISIN | US00182C1036 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,84 Mrd. USD |
| Beta | 0,44 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 883,366,000 | 78,337,000 | 3.32 | 1,440,377,000 | 540,724,000 |
| 2025-09-30 | 10-Q | 227,813,000 | 26,617,000 | 1.13 | 1,408,152,000 | 505,817,000 |
| 2025-06-30 | 10-Q | 211,371,000 | 8,549,000 | 0.36 | 1,343,001,000 | 436,757,000 |
| 2025-03-31 | 10-Q | 197,122,000 | 15,681,000 | 0.69 | 1,292,428,000 | 418,620,000 |
| 2024-12-31 | 10-K | 614,376,000 | -18,522,000 | -1.04 | 1,284,469,000 | 403,680,000 |
| 2024-09-30 | 10-Q | 148,332,000 | -24,166,000 | -1.27 | 1,287,377,000 | 405,948,000 |
| 2024-06-30 | 10-Q | 138,040,000 | -2,287,000 | -0.14 | 920,753,000 | 455,760,000 |
| 2024-03-31 | 10-Q | 137,430,000 | 18,207,000 | 0.82 | 914,524,000 | 451,963,000 |
| 2023-12-31 | 10-K | 486,816,000 | 18,779,000 | 0.85 | 904,422,000 | 432,749,000 |
| 2023-09-30 | 10-Q | 131,829,000 | 9,940,000 | 0.45 | 889,914,000 | 429,861,000 |
| 2023-06-30 | 10-Q | 116,547,000 | 6,245,000 | 0.29 | 859,341,000 | 409,622,000 |
| 2023-03-31 | 10-Q | 106,786,000 | 1,439,000 | 0.06 | 765,224,000 | 314,632,000 |
| 2022-12-31 | 10-K | 316,385,000 | -47,896,000 | -3.05 | 760,087,000 | 313,690,000 |
| 2022-09-30 | 10-Q | 83,821,000 | -8,600,000 | -0.55 | 739,110,000 | 311,825,000 |
| 2022-06-30 | 10-Q | 73,855,000 | -14,923,000 | -0.94 | 751,334,000 | 312,108,000 |
| 2022-03-31 | 10-Q | 64,477,000 | -20,130,000 | -1.27 | 744,846,000 | 321,244,000 |
| 2021-12-31 | 10-K | 216,136,000 | -42,603,000 | -3.40 | 771,598,000 | 333,890,000 |
| 2021-09-30 | 10-Q | 52,061,000 | -4,447,000 | -0.37 | 470,454,000 | 191,403,000 |
| 2021-06-30 | 10-Q | 48,625,000 | -14,106,000 | -1.17 | 480,159,000 | 191,917,000 |
| 2021-03-31 | 10-Q | 54,521,000 | 86,000 | 0.01 | 463,843,000 | 203,712,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13,721,712 | 0 | 13,721,712 | 224,017,964 | Neu | +100,0% | |
| VANGUARD GROUP INC | 1,305,068 | 0 | 1,305,068 | 103,022,068 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 24,539,665 | 0 | 24,539,665 | 72,885,903 | Neu | +100,0% | |
| STATE STREET CORP | 727,204 | 0 | 727,204 | 57,405,484 | Neu | +100,0% | |
| CAMDEN ASSET MANAGEMENT L P /CA | 43,017,000 | 0 | 43,017,000 | 54,072,369 | Neu | +100,0% | |
| Global Alpha Capital Management Ltd. | 590,135 | 0 | 590,135 | 46,585,257 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 487,667 | 0 | 487,667 | 38,497,108 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 486,243 | 0 | 486,243 | 38,384,022 | Neu | +100,0% | |
| Alberta Investment Management Corp | 30,000,000 | 0 | 30,000,000 | 37,922,700 | Neu | +100,0% | |
| Deep Track Capital, LP | 477,684 | 0 | 477,684 | 37,708,375 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 477,272 | 0 | 477,272 | 37,681,704 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 473,207 | 0 | 473,207 | 37,354,961 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 13,253,670 | 0 | 13,253,670 | 35,998,293 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,900,278 | 0 | 1,900,278 | 33,483,446 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 392,576 | 0 | 392,576 | 30,989,950 | Neu | +100,0% | |
| Ranger Investment Management, L.P. | 362,378 | 0 | 362,378 | 28,606,119 | Neu | +100,0% | |
| HBK INVESTMENTS L P | 22,650,000 | 0 | 22,650,000 | 28,589,000 | Neu | +100,0% | |
| Empyrean Capital Partners, LP | 21,000,000 | 0 | 21,000,000 | 26,486,250 | Neu | +100,0% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 316,693 | 0 | 316,693 | 24,999,745 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 314,402 | 0 | 314,402 | 24,818,894 | Neu | +100,0% | |
| CITIGROUP INC | 8,241,971 | 0 | 8,241,971 | 23,719,380 | Neu | +100,0% | |
| Boussard & Gavaudan Investment Management LLP | 18,500 | 0 | 18,500 | 23,580,390 | Neu | +100,0% | |
| MORGAN STANLEY | 1,118,427 | 0 | 1,118,427 | 23,268,029 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 15,033,115 | 0 | 15,033,115 | 21,533,389 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 269,903 | 0 | 269,903 | 21,306,143 | Neu | +100,0% | |
| Caption Management, LLC | 257,773 | 0 | 257,773 | 20,348,601 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 253,536 | 0 | 253,536 | 20,014,132 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 251,629 | 0 | 251,629 | 19,863,593 | Neu | +100,0% | |
| Aberdeen Group plc | 240,792 | 0 | 240,792 | 19,008,121 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 221,298 | 0 | 221,298 | 17,470,000 | Neu | +100,0% | |
| BANK OF MONTREAL /CAN/ | 219,355 | 0 | 219,355 | 17,315,884 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 1,733,573 | 0 | 1,733,573 | 17,216,433 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 217,881 | 0 | 217,881 | 17,199,526 | Neu | +100,0% | |
| KENNEDY CAPITAL MANAGEMENT LLC | 213,801 | 0 | 213,801 | 16,877,451 | Neu | +100,0% | |
| Schonfeld Strategic Advisors LLC | 192,006 | 0 | 192,006 | 15,156,951 | Neu | +100,0% | |
| Invesco Ltd. | 189,836 | 0 | 189,836 | 14,985,653 | Neu | +100,0% | |
| OBERWEIS ASSET MANAGEMENT INC/ | 188,830 | 0 | 188,830 | 14,906,240 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 181,151 | 0 | 181,151 | 14,300,060 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 176,814 | 0 | 176,814 | 13,957,698 | Neu | +100,0% | |
| LOOMIS SAYLES & CO L P | 168,829 | 0 | 168,829 | 13,327,362 | Neu | +100,0% | |
| Context Capital Management, LLC | 10,000,000 | 0 | 10,000,000 | 12,620,000 | Neu | +100,0% | |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 151,275 | 0 | 151,275 | 11,941,649 | Neu | +100,0% | |
| UBS Group AG | 150,779 | 0 | 150,779 | 11,902,493 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 144,357 | 0 | 144,357 | 11,395,541 | Neu | +100,0% | |
| Jefferies Financial Group Inc. | 7,632,000 | 0 | 7,632,000 | 10,591,093 | Neu | +100,0% | |
| Walleye Capital LLC | 117,307 | 0 | 117,307 | 9,260,215 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 108,469 | 0 | 108,469 | 8,562,542 | Neu | +100,0% | |
| NEW YORK STATE COMMON RETIREMENT FUND | 96,735 | 0 | 96,735 | 7,636,261 | Neu | +100,0% | |
| Assenagon Asset Management S.A. | 89,777 | 0 | 89,777 | 7,086,996 | Neu | +100,0% | |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 5,313,348 | 0 | 5,313,348 | 7,031,343 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-13 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -500 | 77.95 | -38,975.00 | -4,8% | |
| 2026-03-13 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -500 | 72.62 | -36,310.00 | -4,5% | |
| 2026-03-13 | Mutz Christopher | Officer, HEAD OF RARE DISEASE | Open Market Sale | -3,162 | 71.64 | -226,525.68 | -28,2% | |
| 2026-03-11 | Rowland Thomas Andrew | Officer, SVP, HEAD - ESTABLISHED BRANDS | Open Market Sale | -4,772 | 74.91 | -357,470.52 | -44,4% | |
| 2026-03-09 | Davis Krista | Officer, SVP, CHIEF HR OFFICER | Open Market Sale | -5,087 | 74.13 | -377,099.31 | -46,9% | |
| 2026-03-09 | Mutz Christopher | Officer, HEAD OF RARE DISEASE | Open Market Sale | -3,602 | 74.18 | -267,196.36 | -33,2% | |
| 2026-03-06 | Mutz Christopher | Officer, HEAD OF RARE DISEASE | Open Market Sale | -2,121 | 74.22 | -157,420.62 | -19,6% | |
| 2026-03-06 | Davis Krista | Officer, SVP, CHIEF HR OFFICER | Open Market Sale | -1,485 | 75.00 | -111,375.00 | -13,8% | |
| 2026-03-05 | CAREY STEPHEN P. | Officer, SVP & CFO | Open Market Sale | -4,000 | 75.56 | -302,240.00 | -37,6% | |
| 2026-03-05 | CAREY STEPHEN P. | Officer, SVP & CFO | Open Market Sale | -3,312 | 75.42 | -249,791.04 | -31,1% | |
| 2026-03-03 | Gutwerg Ori | Officer, SVP, GENERICS | Open Market Sale | -2,060 | 76.50 | -157,590.00 | -19,6% | |
| 2026-03-03 | Walsh Patrick D | Director | Open Market Sale | -6,000 | 74.23 | -445,380.00 | -55,4% | |
| 2026-03-02 | Mutz Christopher | Officer, HEAD OF RARE DISEASE | Open Market Sale | -417 | 74.00 | -30,858.00 | -3,8% | |
| 2026-02-20 | Davis Krista | Officer, SVP, CHIEF HR OFFICER | Open Market Sale | -1,730 | 77.99 | -134,922.70 | -16,8% | |
| 2026-02-20 | Mutz Christopher | Officer, HEAD OF RARE DISEASE | Open Market Sale | -5,323 | 78.02 | -415,300.46 | -51,6% | |
| 2026-02-19 | Davis Krista | Officer, SVP, CHIEF HR OFFICER | Open Market Sale | -2,084 | 77.53 | -161,572.52 | -20,1% | |
| 2026-02-13 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -500 | 76.80 | -38,400.00 | -4,8% | |
| 2026-02-12 | Mutz Christopher | Officer, HEAD OF RARE DISEASE | Open Market Sale | -7,032 | 76.55 | -538,299.60 | -66,9% | |
| 2026-01-13 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -500 | 84.33 | -42,165.00 | -5,2% | |
| 2025-12-18 | Davis Krista | Officer, SVP, CHIEF HR OFFICER | Open Market Sale | -1,622 | 82.40 | -133,652.80 | -16,6% | |
| 2025-12-12 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -400 | 82.32 | -32,928.00 | -4,1% | |
| 2025-12-05 | TANNENBAUM RENEE P | Director | Open Market Sale | -1,800 | 81.15 | -146,070.00 | -18,2% | |
| 2025-11-13 | Gassert Chad | Officer, SVP - CORP. DEV. & STRATEGY | Open Market Sale | -94 | 88.00 | -8,272.00 | -1,0% | |
| 2025-11-13 | Walsh Patrick D | Director | Open Market Sale | -8,643 | 86.88 | -750,903.84 | -93,4% | |
| 2025-11-13 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -400 | 87.27 | -34,908.00 | -4,3% | |
| 2025-11-12 | Gassert Chad | Officer, SVP - CORP. DEV. & STRATEGY | Open Market Sale | -14,642 | 89.07 | -1,304,162.94 | -162,2% | |
| 2025-10-13 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -400 | 90.09 | -36,036.00 | -4,5% | |
| 2025-09-19 | Davis Krista | Officer, SVP, CHIEF HR OFFICER | Open Market Sale | -1,000 | 98.04 | -98,040.00 | -12,2% | |
| 2025-09-12 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -400 | 98.42 | -39,368.00 | -4,9% | |
| 2025-09-03 | Pera Antonio R | Director | Open Market Sale | -7,292 | 94.94 | -692,302.48 | -86,1% | |
| 2025-08-25 | Leonard Matthew J | Director | Open Market Sale | -2,528 | 90.62 | -229,087.36 | -28,5% | |
| 2025-08-22 | Davis Krista | Officer, SVP, CHIEF HR OFFICER | Open Market Sale | -1,763 | 91.10 | -160,609.30 | -20,0% | |
| 2025-08-21 | Shanmugam Muthusamy | Director, Officer, HEAD OF R&D, COO-NOVITIUM OPS | Open Market Sale | -52,988 | 90.44 | -4,792,234.72 | -595,9% | |
| 2025-08-20 | Shanmugam Muthusamy | Director, Officer, HEAD OF R&D, COO-NOVITIUM OPS | Open Market Sale | -47,012 | 90.27 | -4,243,773.24 | -527,7% | |
| 2025-08-20 | Pera Antonio R | Director | Open Market Sale | -5,421 | 89.73 | -486,426.33 | -60,5% | |
| 2025-08-18 | Leonard Matthew J | Director | Open Market Sale | -6,937 | 88.17 | -611,635.29 | -76,1% | |
| 2025-08-18 | Thoma Jeanne | Director | Open Market Sale | -14,675 | 88.87 | -1,304,167.25 | -162,2% | |
| 2025-08-18 | Thoma Jeanne | Director | Open Market Sale | -6,865 | 89.76 | -616,202.40 | -76,6% | |
| 2025-08-15 | Gassert Chad | Officer, SVP - CORP. DEV. & STRATEGY | Open Market Sale | -20,000 | 86.97 | -1,739,400.00 | -216,3% | |
| 2025-08-15 | Shanmugam Muthusamy | Director, Officer, HEAD OF R&D, COO-NOVITIUM OPS | Open Market Sale | -52,990 | 87.15 | -4,618,078.50 | -574,2% | |
| 2025-08-15 | Walsh Patrick D | Director | Open Market Sale | -9,000 | 89.05 | -801,450.00 | -99,7% | |
| 2025-08-14 | Shanmugam Muthusamy | Director, Officer, HEAD OF R&D, COO-NOVITIUM OPS | Open Market Sale | -47,010 | 89.48 | -4,206,454.80 | -523,0% | |
| 2025-08-13 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -400 | 88.87 | -35,548.00 | -4,4% | |
| 2025-08-12 | Gutwerg Ori | Officer, SVP, GENERICS | Open Market Sale | -5,873 | 86.53 | -508,190.69 | -63,2% | |
| 2025-08-12 | Rowland Thomas Andrew | Officer, SVP, HEAD - ESTABLISHED BRANDS | Open Market Sale | -4,975 | 85.71 | -426,407.25 | -53,0% | |
| 2025-08-12 | HAUGHEY THOMAS | Director | Open Market Sale | -19,341 | 85.93 | -1,661,972.13 | -206,7% | |
| 2025-08-12 | CAREY STEPHEN P. | Officer, SVP & CFO | Open Market Sale | -50,000 | 86.07 | -4,303,500.00 | -535,1% | |
| 2025-08-12 | Lalwani Nikhil | Director, Officer, PRESIDENT & CEO | Open Market Sale | -56,960 | 85.93 | -4,894,572.80 | -608,6% | |
| 2025-07-14 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -400 | 64.88 | -25,952.00 | -3,2% | |
| 2025-06-13 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -400 | 61.37 | -24,548.00 | -3,1% | |
| 2025-05-15 | Gutwerg Ori | Officer, SVP, GENERICS | Open Market Sale | -881 | 60.07 | -52,921.67 | -6,6% | |
| 2025-05-14 | Mutz Christopher | Officer, HEAD OF RARE DISEASE | Open Market Sale | -4,000 | 60.45 | -241,800.00 | -30,1% | |
| 2025-05-13 | Cook Meredith | Officer, SR. VP, GENERAL COUNSEL & SEC. | Open Market Sale | -400 | 62.20 | -24,880.00 | -3,1% | |
| 2025-05-09 | Shanmugam Muthusamy | Director, Officer, HEAD OF R&D, COO-NOVITIUM OPS | Open Market Sale | -700 | 76.83 | -53,781.00 | -6,7% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-03-24 | 1 | 73,92 | 74 |
| 2026-02-27 | 653 | 77,15 | 50.379 |
| 2026-02-24 | 6.539 | 75,10 | 491.079 |
| 2026-02-20 | 3.427 | 78,10 | 267.649 |
| 2026-02-19 | 1.022 | 77,81 | 79.522 |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| BlackRock, Inc. | 13,721,712 | 224,017,964 | 13.35 |
| VANGUARD GROUP INC | 1,305,068 | 103,022,068 | 6.14 |
| MILLENNIUM MANAGEMENT LLC | 24,539,665 | 72,885,903 | 4.34 |
| STATE STREET CORP | 727,204 | 57,405,484 | 3.42 |
| CAMDEN ASSET MANAGEMENT L P /CA | 43,017,000 | 54,072,369 | 3.22 |
| Global Alpha Capital Management Ltd. | 590,135 | 46,585,257 | 2.78 |
| DIMENSIONAL FUND ADVISORS LP | 487,667 | 38,497,108 | 2.29 |
| Soleus Capital Management, L.P. | 486,243 | 38,384,022 | 2.29 |
| Alberta Investment Management Corp | 30,000,000 | 37,922,700 | 2.26 |
| Deep Track Capital, LP | 477,684 | 37,708,375 | 2.25 |
| GEODE CAPITAL MANAGEMENT, LLC | 477,272 | 37,681,704 | 2.25 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 473,207 | 37,354,961 | 2.23 |
| JPMORGAN CHASE & CO | 13,253,670 | 35,998,293 | 2.15 |
| GOLDMAN SACHS GROUP INC | 1,900,278 | 33,483,446 | 2.00 |
| DEUTSCHE BANK AG\ | 392,576 | 30,989,950 | 1.85 |
| Ranger Investment Management, L.P. | 362,378 | 28,606,119 | 1.70 |
| HBK INVESTMENTS L P | 22,650,000 | 28,589,000 | 1.70 |
| Empyrean Capital Partners, LP | 21,000,000 | 26,486,250 | 1.58 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 316,693 | 24,999,745 | 1.49 |
| RENAISSANCE TECHNOLOGIES LLC | 314,402 | 24,818,894 | 1.48 |